Free tool
FAERS Monitor: Diacomit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 207223 or its brand name (Diacomit, Stiripentol). Reports on generic versions are filed under their own applications.
Reports
2,283
Serious
1,959
86% of reports
Hospitalization
765
Death reported
121
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure928
- off label use443
- product use in unapproved indication351
- drug ineffective306
- decreased appetite265
- somnolence246
- product preparation issue201
- product dose omission issue186
- fatigue138
- pyrexia113
- weight decreased111
- hospitalisation107
- generalised tonic-clonic seizure90
- diarrhoea84
- pneumonia84
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 12 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 21 |
| 2016 | 14 |
| 2017 | 42 |
| 2018 | 50 |
| 2019 | 239 |
| 2020 | 247 |
| 2021 | 284 |
| 2022 | 276 |
| 2023 | 186 |
| 2024 | 234 |
| 2025 | 303 |
| 2026 | 337 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,876 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product preparation issueSignal | 201 | 291.2 | 254.6 | 56,086 |
| seizureSignal | 928 | 74.6 | 71.0 | 67,148 |
| generalised tonic-clonic seizureSignal | 90 | 50.4 | 41.1 | 4,286 |
| product use in unapproved indicationSignal | 351 | 13.1 | 11.9 | 3,939 |
| somnolenceSignal | 246 | 11.3 | 10.0 | 2,311 |
| decreased appetiteSignal | 265 | 10.5 | 9.4 | 2,297 |
| hospitalisationSignal | 107 | 6.4 | 5.3 | 487 |
| product dose omission issueSignal | 186 | 5.8 | 5.1 | 750 |
| off label useSignal | 443 | 4.7 | 4.3 | 1,326 |
| weight decreasedSignal | 111 | 3.7 | 3.1 | 215 |
| pyrexiaSignal | 113 | 3.0 | 2.5 | 152 |
| pneumoniaSignal | 84 | 2.4 | 1.9 | 68 |
| drug ineffectiveSignal | 306 | 2.1 | 1.9 | 197 |
| fatigue | 138 | 1.6 | 1.4 | 35 |
| diarrhoea | 84 | 1.2 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.